A potential new Alzheimer's drug represses the harmful inflammatory response of the brain's immune cells, reducing disease pathology, preserving neurons and improving cognition in preclinical tests.
from Healthy Aging News -- ScienceDaily https://ift.tt/5SgkUBJ
No comments:
Post a Comment